Pneumococcal resistance patterns in Europe

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 16, Issue 9, 1997, Pages 644-647

  Pradier, C ^a   Dunais, B ^a   Carsenti Etesse, H ^a   Dellamonica, P ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PENICILLIN G;

ARTICLE; FRANCE; GERMANY; HUNGARY; ICELAND; ITALY; NONHUMAN; PATIENT COMPLIANCE; PENICILLIN RESISTANCE; PREVALENCE; PRIORITY JOURNAL; SPAIN; STREPTOCOCCUS PNEUMONIAE; UNITED KINGDOM;

ANTI-BACTERIAL AGENTS; EUROPE; HUMANS; PATIENT COMPLIANCE; PENICILLIN RESISTANCE; PNEUMOCOCCAL INFECTIONS; PREVALENCE; STREPTOCOCCUS PNEUMONIAE;

EID: 0030859528     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01708553     Document Type: Article

References (21)

1. Dowson CG, Hutchison A, Brannigan JA, George RC, Hansman D, Linares J, Tomasz A, Smith JM, Spratt BG: Horizontal transfer of penicillin-binding protein genes in penicillin-resistant clinical isolates of Streptococcus pneumoniae. Proceedings of the National Academy of Sciences of the USA 1989, 86: 8842-8846.
2. Sifaoui F, Kitzis MD, Gutmann L: In vitro selection of one-step mutants of Streptococcus pneumoniae resistant to different oral β-lactam antibiotics is associated with alterations of PBP2x. Antimicrobial Agents and Chemotherapy 1996, 40: 152-156.
3. Carsenti-Etesse H, Durant J, De Salvador F, Bensoussan M, Pradier C, Thabaut A, Dellamonica P: In vitro development of resistance of Streptococcus pneumoniae to β-lactam antibiotics. Microbial Drug Resistance 1995, 1: 85-94.
4. Baquero F, Martinez-Beltran J, Loza E: A review of antibiotic resistance patterns of Streptococcus in Europe. Journal of Antimicrobial Chemotherapy 1991, 28, Supplement C: 31-38.
5. Munoz R, Musser JM, Crain M, Briles DE, Marton A, Parkinson AJ, Sorenson U, Tomasz A: Geographic distribution of penicillin-resistant clones of Streptococcus pneumoniae: characterization by penicillin-binding profile, surface-protein A typing, and multi-locus enzyme analysis. Clinical Infectious Diseases 1992, 15: 112-118.
6. Baquero F: Evolution de la résistance du pneumocoque en Espagne: un modèle prédictif. Médecine et Maladies Infectieuses 1994; 24: 241-246.
7. Geslin R Fremaux A, Sissia G, Spicq C, Aberrane S: Epidémiologie de la résistance aux antibiotiques de Streptococcus pneumoniae en France. Réseau national du surveillance (1984-1993). Médecine et Maladies Infectieuses 1994, 24, Spécial: 948-961.
8. Reinert RR, Queck A, Kaufhold A, Kresken M, Lütticken R: Antimicrobial resistance and type distribution of Streptococcus pneumoniae isolates causing systemic infections in Germany, 1992-1994. Clinical Infectious Diseases 1995, 21: 1398-1401.
9. Marchese A, Debbia EA, Arvigo A, Pesce A, Schito GC: Susceptibility of Streptococcus strains isolated in Italy to penicillin and ten other antibiotics. Journal of Antimicrobial Chemotherapy 1995, 36: 833-837.
10. Ridgway EJ, Tremlett CH, Allen KD: Capsular serotypes and antibiotic sensitivity of Streptococcus pneumoniae isolated from primary-school children. Journal of Infection 1995, 30: 245-251.
11. Lecomte T, Paris V: Consommation de pharmacie en Europe - Allemagne, France, Italie, Royaume Uni. In: Consommation de pharmacie en Europe, 1992. The Centre de Recherche d'Etude et Documentation en Economie de la Santé, Paris, 1994, p. 27-37.
12. Branthwaite A, Péchère JC: Pan-European survey of patients' attitudes to antibiotics and antibiotic use. Journal of Internal Medicine Research 1996, 24: 229-238.
13. Sclar DA, Tartaglione TA, Fine MJ: Overview of issues related to medical compliance with implications for out-patient management of infectious diseases. Infectious Agents and Disease 1994, 3: 266-273.
14. Bédos JP, Chevret S, Chastang CI, Geslin P, Régnier B, and the French Cooperative Pneumococcus Study Group: Epidemiological features of and risk factors for infection by Streptococcus pneumoniae strains with diminished sensitivity to penicillin: findings of a French survey. Clinical Infectious Diseases 1996, 22: 63-72.
15. Nava J, Bella F, Garau J, Lite J, Morera MA, Mart C, Fontanals D, Font B, Pineda V, Uriz S, Deulofeu F, Calderon A, Duran P, Grau M, Agudo A: Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study. Clinical Infectious Diseases 1994, 19: 884-890.
16. Baquero F: Trends in antibiotic resistance of respiratory pathogens: an analysis and commentary on a collaborative surveillance study. Journal of Antimicrobial Chemotherapy 1996, 38, Supplement A: 117-132.
17. Eisen S, Miller DK, Woodward RS, Spitznagel E, Przybeck TR: The effect of prescribed daily dose frequency on patient medication compliance. Archives of Internal Medicine 1990, 150: 1881-1884.
18. Greenberg RN: Overview of patient compliance with medication dosing: a literature review. Clinical Therapeutics 1984, 6: 592-599.
19. Holmes SJ, Morrow AL, Pickering LK: Child-care practices: effects of social change on the epidemiology of infectious diseases and antibiotic resistance. Epidemiological Reviews 1996, 18: 10-28.
20. Taboulet F: Présentation d'une méthodologie permettant de mesurer en quantité et de comparer les consommations pharmaceutiques. Journal d'Economie Médicale 1990, 8: 37-63.
21. Nowak R: Hungary sees an improvement in penicillin resistance. Science 1994, 264: 364.